Association of polymorphisms within the transforming growth factor‐β1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations

Aim:  The TGF‐β gene participates in the development of chronic kidney disease. We investigated whether the 869 T > C, 915 G > C and −800 G > A polymorphisms of TGF‐β1 are associated with diabetic nephropathy (DN).

[1]  A. Esteghamati,et al.  Association of macroalbuminuria with oxidized LDL and TGF-β in type 2 diabetic patients: a case–control study , 2010, International Urology and Nephrology.

[2]  J. Svensson,et al.  Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice. , 2009, Atherosclerosis.

[3]  A. Esteghamati,et al.  Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study. , 2009, Translational research : the journal of laboratory and clinical medicine.

[4]  Richard A Flavell,et al.  Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. , 2008, Immunity.

[5]  L. Lerman,et al.  Role of Renal Cortical Neovascularization in Experimental Hypercholesterolemia , 2007, Hypertension.

[6]  R. Paniagua,et al.  Chronic Kidney Disease and Dialysis in Mexico , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  Rajeev Gupta,et al.  Association of TGFβ1, TNFα, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians , 2007, BMC Medical Genetics.

[8]  R. D. Mittal,et al.  Is low-frequency distribution of TGF-beta genotype associated with increased risk for end-stage renal disease? , 2007, DNA and cell biology.

[9]  C. Hurley,et al.  A molecular mechanism for the differential regulation of TGF-β1 expression due to the common SNP −509C-T (c. −1347C > T) , 2006, Human Genetics.

[10]  C. Hurley,et al.  Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms , 2006, Human Genetics.

[11]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[12]  L. Lerman,et al.  Pathways of Renal Fibrosis and Modulation of Matrix Turnover in Experimental Hypercholesterolemia , 2005, Hypertension.

[13]  A. Blakemore,et al.  Transforming Growth Factor-β1 SNPs: Genetic and Phenotypic Correlations in Progressive Kidney Insufficiency , 2005, Nephron Experimental Nephrology.

[14]  P. Jacobsen.  Preventing end stage renal disease in diabetic patients — genetic aspect (part I) , 2005, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[15]  B. Cormand,et al.  Association of TGF-beta1 polymorphisms with chronic renal disease. , 2004, Journal of nephrology.

[16]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[17]  C. Napoli,et al.  Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. , 2003, Kidney international.

[18]  K. Chow,et al.  Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. , 2003, Kidney international.

[19]  L. Lerman,et al.  Angiotensin II AT1 receptor blockade improves renal perfusion in hypercholesterolemia. , 2003, American journal of hypertension.

[20]  T. Ohtsuka,et al.  The polymorphism of transforming growth factor‐β1 gene in Japanese patients with systemic sclerosis , 2002, The British journal of dermatology.

[21]  C. Napoli,et al.  Distinct Renal Injury in Early Atherosclerosis and Renovascular Disease , 2002, Circulation.

[22]  T. Kita,et al.  Transforming Growth Factor-β1 Increases the Expression of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 , 2000 .

[23]  T. Rabelink,et al.  Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. , 2000, Journal of the American Society of Nephrology : JASN.

[24]  A. Arredondo,et al.  Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. , 2004, Diabetes care.

[25]  C. Hill,et al.  New insights into TGF-beta-Smad signalling. , 2004, Trends in biochemical sciences.

[26]  G. Viberti,et al.  Pathogenesis of diabetic nephropathy. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[27]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.